LEUKEMIA & LYMPHOMA SOCIETY
Leukemia & Lymphoma Society, a voluntary health organization, funds research, finds cures, and offers treatments for blood cancer patients.
LEUKEMIA & LYMPHOMA SOCIETY
Founded:
1944-01-01
Status:
Active
Contact:
(800) 482-8326
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache IPv6 Google Maps
Current Advisors List
Guy Chiarello Member of the Advisory Board @ Leukemia & Lymphoma Society Advisor
Richard Iorio Board Member @ Leukemia & Lymphoma Society Board_member 2018-01-01
Michael O'Neil Board of Directors @ Leukemia & Lymphoma Society Board_member
Eric Allen Board Member @ Leukemia & Lymphoma Society Board_member 2018-07-01
M. Preston Clarke Board of Trustees, LLS Arizona Chapter @ Leukemia & Lymphoma Society Board_member 2017-01-01
Saurabh Saha MD PhD Board of Trustees @ Leukemia & Lymphoma Society Board_member
Current Employees Featured
Guy P. Nohra
Guy P. Nohra President @ Leukemia & Lymphoma Society President
Larry Saltzman
Larry Saltzman Executive Research Director @ Leukemia & Lymphoma Society Executive Research Director 2014-01-01
Michael Burke
Michael Burke Chairman of Board @ Leukemia & Lymphoma Society Chairman of Board 2013-01-01
Lee Greenberger
Lee Greenberger CSO @ Leukemia & Lymphoma Society CSO
Ron Kraft
Ron Kraft First Connections - Volunteer @ Leukemia & Lymphoma Society First Connections - Volunteer 2015-03-01
Jim Reddoch
Jim Reddoch Therapy Acceleration Program (TAP) @ Leukemia & Lymphoma Society Therapy Acceleration Program (TAP) 2021-05-01
Howard Buff
Howard Buff Treasurer @ Leukemia & Lymphoma Society Treasurer
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-13 | ImCheck Therapeutics | Leukemia & Lymphoma Society investment in Series C - ImCheck Therapeutics | 96 M EUR |
2021-08-18 | Immunitas Therapeutics | Leukemia & Lymphoma Society investment in Series B - Immunitas Therapeutics | 58 M USD |
2021-03-30 | Immune-Onc Therapeutics | Leukemia & Lymphoma Society investment in Series B - Immune-Onc Therapeutics | 73 M USD |
2021-03-03 | Caribou Biosciences | Leukemia & Lymphoma Society investment in Series C - Caribou Biosciences | 115 M USD |
2020-03-12 | Kymera Therapeutics | Leukemia & Lymphoma Society investment in Corporate Round - Kymera Therapeutics | N/A |
2019-08-12 | University of Arkansas for Medical Sciences | Leukemia & Lymphoma Society investment in Grant - University of Arkansas for Medical Sciences | 542.49 K USD |
2019-08-07 | Forty Seven | Leukemia & Lymphoma Society investment in Post-IPO Equity - Forty Seven | 6 M USD |
2014-08-28 | OncoPep | Leukemia & Lymphoma Society investment in Series B - OncoPep | 6.9 M USD |
2011-06-23 | Epizyme | Leukemia & Lymphoma Society investment in Venture Round - Epizyme | 7.5 M USD |
Key Employee Changes
Date | New article |
---|---|
2020-03-02 | The Leukemia & Lymphoma Society Announces New Chief Operating Officer, Chief Marketing Officer and General Counsel |